Blog Post

Blog Post

Zogenix Announces Positive Results from Pivotal Study of Investigational Treatment MT1621 for TK2 Deficiency

By Jeanene Swanson | December 2, 2019
MDA logo
Blog Post

Santhera Pharmaceuticals Releases Letter to DMD Community Announcing Temporary Suspension of Enrollment in BreatheDMD Expanded Access Program

By MDA Staff | November 26, 2019
Blog Post

NALC to Deliver the Cure for MDA on #GivingTuesday

By MDA Staff | November 21, 2019
Blog Post

Fire Fighter, Father, Friend: JR Ortiz Bolsters MDA, From Boston to New York City

By Lindsey Baker | November 20, 2019
Blog Post

Roche Genentech Announces Positive Results from Pivotal Study of Risdiplam in SMA Types 2 and 3

By Jeanene Swanson | November 15, 2019
Blog Post

What’s #GivingTuesday All About?

By MDA Staff | November 12, 2019
MDA logo
Blog Post

Solid Biosciences Releases Letter to DMD Community Announcing Hold on IGNITE DMD Trial Due to a Serious Adverse Event

By MDA Staff | November 12, 2019
Blog Post

Roche Genentech Releases Letter to DMD Community Announcing Discontinuation of Clinical Trials Program for DMD

By MDA Staff | November 6, 2019
Blog Post

MDA Care Centers Combine Expert Care with Research, Clinical Trials, and Advanced Technology

By Jeanene Swanson | November 5, 2019
MDA logo
Blog Post

AveXis Releases Letter to SMA Community: FDA Places Partial Hold on Clinical Trials for Intrathecally Delivered AVXS-101

By MDA Staff | November 1, 2019